Phibro Animal Health Corporation provided consolidated earnings guidance for the year ending June 30, 2024. For the year, the company expects Net sales of $980 million to $1.02 billion, growth of 2%, Net income of $23 million to $28 million, a decline of 22% and Diluted EPS of $0.57 to $0.69, a decline of 22%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.73 USD | +2.33% | -4.29% | +9.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.93% | 516M | |
-19.73% | 72.39B | |
-11.01% | 6.54B | |
+15.88% | 3.43B | |
-2.92% | 3.12B | |
-0.68% | 1.4B | |
-17.27% | 1.34B | |
-2.73% | 1.26B | |
-28.16% | 1.2B | |
-14.67% | 1.12B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024